In patients post-myocardial infarction with hypertension, comprehensive risk factor management including fixed-dose combinations of ACE inhibitors and beta-blockers is crucial for secondary prevention and improving adherence.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Michaela Šnejdrlová (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: